13
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Immunohistochemical Staining of Lymphocytes for the Reliable Diagnosis of Myocarditis in Endomyocardial Biopsies

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Interobserver variability in the interpretation of pathologic endomyocardial biopsies for detecting myocarditis has been widely reported. Thus, conflicting reports about the therapeutic benefit of immunosuppressive treatment in myocarditis may be due to differences in the interpretation of the biopsy findings. In doubtful cases, scattered interstitial cells may be present between myocytes and can be misinterpreted as true lymphocytes. In our study, a further characterization of interstitial cells in endomyocardial biopsies previously diagnosed as showing ‘myocarditis’ was performed by lymphocyte immunophenotyping with immunocytochemical techniques for membrane and cytoplasmic antigens. Common leukocyte antigen (CLA), k and λ light immunoglobulin chains and T lymphocyte antigens were made visible by an indirect immunoperoxidase technique. A previous diagnosis of ‘myocarditis’ had been established histologically in 27 patients by the presence of an inflammatory cell infiltrate associated with focal acute cellular damage. These specimens were selected for further study using an immunoperoxidase technique. The number of negative and positive mononuclear cells for each marker was counted on all fields at a magnification of × 400. These numbers were correlated with the extent of interstitial fibrosis and/or myocyte damage on each sample. According to previous studies, 5.0 lymphocytes/high-power field were considered as the lower limit of myocarditis if they were associated with myocyte injury. From the 27 samples previously diagnosed histologically as ‘myocarditis’ only 14 showed 5 or more CLA-positive mononuclear cells/ × 400 field. In 6 out of 8 selected cases having less than 5 CLA-positive cells, no T-antigen-positive cells could be detected. The remaining samples showed T lymphocytes localized in acute infiltrated areas. From these results, only 14 of the 27 patients showed ‘true myocarditis’. Accordingly, when total cell infiltrates and lymphocytes were evaluated, it was shown that although a high mean of apparently mononuclear cells may be found in a high-power microscopic field, only a small percentage of them may result in true lymphocytes. The present approach facilitates the subclassification and quantification of the different subsets of inflammatory cells and helps to define adequate therapeutic and/or prognostic implications, thus avoiding interobserver variability.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1990
          1990
          12 November 2008
          : 77
          : 2
          : 77-85
          Affiliations
          Cardiopsis, Hospital Fernández, Instituto de Estudios Oncológicos, Instituto de Cardiologia, Hospital Español, Buenos Aires, Argentina
          Article
          174587 Cardiology 1990;77:77–85
          10.1159/000174587
          2144466
          626ac975-e164-4c85-8741-d2021cfa6ab4
          © 1990 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 05 September 1989
          : 04 January 1990
          Page count
          Pages: 9
          Categories
          Original Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Immunohistochemical staining,Immunoperoxidase technique,Endomyocardial biopsy,T lymphocytes,Viral myocarditis,Myocarditis

          Comments

          Comment on this article